Primary |
Contraception |
89.7% |
Product Used For Unknown Indication |
6.0% |
Depression |
0.5% |
Epilepsy |
0.4% |
Seasonal Allergy |
0.4% |
Menstruation Irregular |
0.4% |
Migraine |
0.4% |
Maternal Exposure During Pregnancy |
0.3% |
Dystonia |
0.3% |
Menorrhagia |
0.2% |
Sinusitis |
0.2% |
Headache |
0.2% |
Menstrual Disorder |
0.2% |
Nausea |
0.2% |
Endometriosis |
0.1% |
Maternal Drugs Affecting Foetus |
0.1% |
Menstrual Cycle Management |
0.1% |
Acne |
0.1% |
Anaemia |
0.1% |
Anxiety |
0.1% |
|
Product Quality Issue |
30.7% |
No Adverse Event |
25.8% |
Unintended Pregnancy |
5.8% |
Metrorrhagia |
4.6% |
Medical Device Complication |
4.0% |
Menorrhagia |
3.3% |
Adverse Event |
2.6% |
Weight Increased |
2.4% |
Pain In Extremity |
2.3% |
Implant Site Pain |
2.3% |
Menstruation Irregular |
2.2% |
Device Breakage |
2.2% |
Vaginal Haemorrhage |
1.9% |
Device Difficult To Use |
1.6% |
Implant Site Pruritus |
1.6% |
Haemorrhage |
1.5% |
Vomiting |
1.4% |
Nausea |
1.3% |
Pregnancy With Implant Contraceptive |
1.3% |
Device Kink |
1.1% |
|
Secondary |
Contraception |
77.3% |
Product Used For Unknown Indication |
7.6% |
Bipolar Disorder |
4.2% |
Seasonal Allergy |
2.7% |
Epilepsy |
1.5% |
Menstruation Irregular |
1.2% |
Sinusitis |
0.7% |
Endometriosis |
0.5% |
Local Anaesthesia |
0.5% |
Maternal Exposure During Pregnancy |
0.5% |
Menorrhagia |
0.5% |
Menstrual Disorder |
0.5% |
Prophylaxis |
0.5% |
Psychotic Disorder |
0.5% |
Adverse Event |
0.2% |
Hay Fever |
0.2% |
Menstrual Cycle Management |
0.2% |
Menstruation Normal |
0.2% |
Mood Swings |
0.2% |
Prenatal Care |
0.2% |
|
Product Quality Issue |
54.9% |
No Adverse Event |
27.1% |
Medical Device Complication |
4.0% |
Pregnancy With Implant Contraceptive |
1.6% |
Device Difficult To Use |
1.4% |
Overdose |
1.3% |
Unintended Pregnancy |
1.3% |
Device Breakage |
0.8% |
Implant Site Pain |
0.8% |
Implant Site Pruritus |
0.8% |
Maternal Exposure During Pregnancy |
0.8% |
Device Kink |
0.6% |
Pain In Extremity |
0.6% |
Pulmonary Embolism |
0.6% |
Weight Increased |
0.6% |
Wrong Technique In Drug Usage Process |
0.6% |
Condition Aggravated |
0.5% |
Infection |
0.5% |
Menorrhagia |
0.5% |
Pain |
0.5% |
|
Concomitant |
Contraception |
48.6% |
Product Used For Unknown Indication |
28.6% |
Depression |
17.1% |
Post Coital Contraception |
2.9% |
Psoriasis |
2.9% |
|
No Adverse Event |
25.0% |
Weight Increased |
16.7% |
Vomiting |
12.5% |
Embedded Device |
4.2% |
Implant Site Fibrosis |
4.2% |
Medical Device Complication |
4.2% |
Menstruation Irregular |
4.2% |
Pelvic Pain |
4.2% |
Product Quality Issue |
4.2% |
Pruritus |
4.2% |
Rash Maculo-papular |
4.2% |
Suicidal Ideation |
4.2% |
Vaginal Haemorrhage |
4.2% |
Wrist Surgery |
4.2% |
|
Interacting |
Seasonal Allergy |
23.1% |
Contraception |
19.2% |
Epilepsy |
19.2% |
Sinusitis |
19.2% |
Product Used For Unknown Indication |
11.5% |
Bipolar Disorder |
5.8% |
Tuberculosis |
1.9% |
|
Epilepsy |
46.2% |
Drug Interaction |
15.4% |
Condition Aggravated |
7.7% |
Convulsion |
7.7% |
Pregnancy With Contraceptive Device |
7.7% |
Unintended Pregnancy |
7.7% |
Unwanted Pregnancy |
7.7% |
|